{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:56Z","timestamp":1791704816370,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NNSF 82303695"],"award-info":[{"award-number":["NNSF 82303695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["HYXH2023070"],"award-info":[{"award-number":["HYXH2023070"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.102990","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:48:03Z","timestamp":1788950883000},"page":"102990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Transmembrane glycoprotein BSG serves a dual role as a prognostic and immunological modulator in the tumor microenvironment of lung adenocarcinoma"],"prefix":"10.1016","volume":"73","author":[{"given":"Xiaofei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiliang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuaile","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2026.102990_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"10299","key":"10.1016\/j.tranon.2026.102990_bib0002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.tranon.2026.102990_bib0003","article-title":"Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways","volume":"3","author":"Soltis","year":"2022","journal-title":"Cell. Rep. Med."},{"issue":"9","key":"10.1016\/j.tranon.2026.102990_bib0004","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/JTO.0000000000000618","article-title":"Prognostic factors of survival after recurrence in patients with resected lung adenocarcinoma","volume":"10","author":"Hung","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102990_bib0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/jb\/mvv127","article-title":"Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners","volume":"159","author":"Muramatsu","year":"2016","journal-title":"J. Biochem."},{"issue":"2","key":"10.1016\/j.tranon.2026.102990_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020507","article-title":"Extracellular matrix metalloproteinase inducer EMMPRIN (CD147) in cardiovascular disease","volume":"19","author":"von Ungern-Sternberg","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102990_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113983","article-title":"CD147 and MMPs as key factors in physiological and pathological processes","volume":"157","author":"Asgari","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tranon.2026.102990_bib0008","article-title":"Large-scale single-cell and bulk sequencing analyses reveal the prognostic value and immune aspects of CD147 in Pan-cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.tranon.2026.102990_bib0009","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/s41423-020-00570-y","article-title":"CD147 regulates antitumor CD8(+) T-cell responses to facilitate tumor-immune escape","volume":"18","author":"Chen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102990_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cell.2018.03.042","article-title":"The cancer genome atlas: creating lasting value beyond its data","volume":"173","author":"Hutter","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.tranon.2026.102990_bib0011","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"Consortium","year":"2013","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.tranon.2026.102990_bib0012","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative proteomics of the cancer Cell Line encyclopedia","volume":"180","author":"Nusinow","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.tranon.2026.102990_bib0013","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","article-title":"Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas","volume":"72","author":"Okayama","year":"2012","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.tranon.2026.102990_bib0014","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.tranon.2026.102990_bib0015","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.tranon.2026.102990_bib0016","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"D1","key":"10.1016\/j.tranon.2026.102990_bib0017","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.tranon.2026.102990_bib0018","doi-asserted-by":"crossref","first-page":"W60","DOI":"10.1093\/nar\/gky311","article-title":"GeneMANIA update 2018","volume":"46","author":"Franz","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.tranon.2026.102990_bib0019","doi-asserted-by":"crossref","first-page":"D330","DOI":"10.1093\/nar\/gky1055","article-title":"The Gene Ontology C. The Gene Ontology resource: 20 years and still going strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.tranon.2026.102990_bib0020","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: integrating viruses and cellular organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.tranon.2026.102990_bib0021","doi-asserted-by":"crossref","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: analyzing multi-omics data within and across 32 cancer types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tranon.2026.102990_bib0022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.tranon.2026.102990_bib0023","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.tranon.2026.102990_bib0024","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00262-016-1797-6","article-title":"Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic","volume":"65","author":"Majchrzak","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"issue":"11","key":"10.1016\/j.tranon.2026.102990_bib0025","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/tri.13475","article-title":"T-cell receptor and B-cell receptor repertoire profiling in adaptive immunity","volume":"32","author":"Minervina","year":"2019","journal-title":"Transpl. Int."},{"issue":"1","key":"10.1016\/j.tranon.2026.102990_bib0026","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/imr.12772","article-title":"T cell receptor-based cancer immunotherapy: emerging efficacy and pathways of resistance","volume":"290","author":"Chandran","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tranon.2026.102990_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100907","article-title":"Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1\/PD-L1 blockade","volume":"66","author":"Pang","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.tranon.2026.102990_bib0028","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40364-021-00338-0","article-title":"The role of ferroptosis in lung cancer","volume":"9","author":"Wu","year":"2021","journal-title":"Biomark Res."},{"issue":"24","key":"10.1016\/j.tranon.2026.102990_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413335","article-title":"Ferroptosis in non-small cell lung cancer: progression and therapeutic potential on it","volume":"22","author":"Zou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102990_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2022.05.011","article-title":"Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: focus on novel therapies","volume":"170","author":"Johnson","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.tranon.2026.102990_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101364","article-title":"The PI3K\/akt\/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles","volume":"18","author":"Sanaei","year":"2022","journal-title":"Transl. Oncol."},{"issue":"8","key":"10.1016\/j.tranon.2026.102990_bib0032","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41584-021-00639-6","article-title":"Insights into the biology and therapeutic implications of TNF and regulatory T cells","volume":"17","author":"Salomon","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"11","key":"10.1016\/j.tranon.2026.102990_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115703","article-title":"Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target","volume":"22","author":"Infantino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102990_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1024423","article-title":"The cAMP-signaling cancers: clinically-divergent disorders with a common central pathway","volume":"13","author":"Bolger","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.tranon.2026.102990_bib0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-020-00949-4","article-title":"The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy","volume":"13","author":"Yuan","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.tranon.2026.102990_bib0036","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/1078-0432.CCR-20-3913","article-title":"Targeting oxidative phosphorylation to increase the efficacy of radio- and Immune-combination therapy","volume":"27","author":"Boreel","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.102990_bib0037","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41421-025-00777-1","article-title":"A basigin antibody modulates MCTs to impact tumor metabolism and immunity[J]","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell. Discov."},{"key":"10.1016\/j.tranon.2026.102990_bib0038","article-title":"Silencing of CD147 inhibits proliferation, invasion and regulates lipid metabolism through blocking the Rap1 pathway in lung adenocarcinoma[J]","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.tranon.2026.102990_bib0039","article-title":"Targeted anti-tumor immunotherapy using tumor infiltrating cells","volume":"8","author":"Xie","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"issue":"7","key":"10.1016\/j.tranon.2026.102990_bib0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41576-021-00329-9","article-title":"Genetic engineering of T cells for immunotherapy","volume":"22","author":"Ellis","year":"2021","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.tranon.2026.102990_bib0041","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41423-018-0027-x","article-title":"Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer","volume":"16","author":"Wang","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102990_bib0042","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK cell-based cancer immunotherapy: from basic biology to clinical development","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102990_bib0043","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"29","key":"10.1016\/j.tranon.2026.102990_bib0044","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"CD147-K148me2-Driven tumor cell-macrophage crosstalk provokes NSCLC immunosuppression via the CCL5\/CCR5 axis[J]","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"issue":"Pt 3","key":"10.1016\/j.tranon.2026.102990_bib0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semcancer.2022.03.014","article-title":"Immune checkpoint proteins: signaling mechanisms and molecular interactions in cancer immunotherapy","volume":"86","author":"Gaikwad","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102990_bib0046","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13045-022-01325-0","article-title":"Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts","volume":"15","author":"Wang","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.tranon.2026.102990_bib0047","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.trecan.2022.04.001","article-title":"Utilizing chemokines in cancer immunotherapy","volume":"8","author":"Markl","year":"2022","journal-title":"Trends Cancer"},{"issue":"23","key":"10.1016\/j.tranon.2026.102990_bib0048","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.3390\/cancers13236132","article-title":"Multifaceted roles of Chemokines and Chemokine receptors in tumor immunity","volume":"13","author":"Matsuo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tranon.2026.102990_bib0049","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and chemokine receptors: new targets for cancer immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.tranon.2026.102990_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.844866","article-title":"Mechanisms of MHC-I downregulation and role in immunotherapy response","volume":"13","author":"Taylor","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.tranon.2026.102990_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101710","article-title":"MHC-dressing on dendritic cells: boosting anti-tumor immunity via unconventional tumor antigen presentation","volume":"66","author":"Chatterjee","year":"2023","journal-title":"Semin Immunol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102990_bib0052","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/imm.13114","article-title":"Cancer immune escape: MHC expression in primary tumours versus metastases","volume":"158","author":"Garrido","year":"2019","journal-title":"Immunology"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:28:13Z","timestamp":1791703693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":52,"alternative-id":["S1936523326003268"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102990","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transmembrane glycoprotein BSG serves a dual role as a prognostic and immunological modulator in the tumor microenvironment of lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102990"}}